BOVNF OTC
BioInvent International AB (publ)
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -30.0%
5Y: -28.8%
$3.29
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$226M
+405.6% ▲
5Y CAGR: +8.9%
Gross Profit
$226M
+406.9% ▲
5Y CAGR: +9.0%
Operating Income
-$351M
+25.6% ▲
Net Income
-$332M
+22.7% ▲
EPS (Diluted)
$-5.07
+22.4% ▲
EBITDA
-$331M
+28.1% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $19M | $326M | $71M | $45M | $226M |
| YoY Growth | -86.8% | +1582.4% | -78.1% | -37.5% | +405.6% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $19M | $326M | $71M | $45M | $226M |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.3% |
| R&D Expenses | $258M | $326M | $390M | $458M | $503M |
| SG&A Expenses | $39M | $51M | $52M | $58M | $74M |
| Operating Expenses | $298M | $377M | $441M | $516M | $578M |
| Operating Income | -$278M | -$51M | -$370M | -$471M | -$351M |
| Operating Margin | -1436.0% | -15.6% | -517.7% | -1054.2% | -155.1% |
| Interest Expense | $517K | $650K | $638K | $555K | $0 |
| Income Before Tax | -$278M | -$43M | -$330M | -$429M | -$332M |
| Tax Expense | $0 | $0 | $204K | $135K | $396K |
| Net Income | -$279M | -$34M | -$330M | -$429M | -$332M |
| Net Margin | -1439.1% | -10.5% | -462.2% | -960.9% | -147.0% |
| EPS (Diluted) | $-5.15 | $-0.55 | $-5.02 | $-6.53 | $-5.07 |
| EBITDA | -$263M | -$27M | -$313M | -$460M | -$331M |
| Shares Outstanding | 54M | 62M | 66M | 66M | 66M |